MARII
  • Home
  • About
  • Events
  • Research
  • News
  • Modeling human exposure to microplastic

    April 16, 2024

    Researchers / Institutional Affiliations

    Principal Investigator

    • Dr. Bart Koelmans
      Wageningen University
      (The Netherlands)

    Collaborators

    N/A

    Timeline

    Summer 2022 to summer 2024 (Cefic Long-Range Research Initiative (LRI)) with two years’ additional funding from PlasticsEurope

    Additional Information

    This project builds on an existing model for human microplastics exposure published by Nor et al (2021). The Nor approach is a promising way to probabilistically model exposure – using a statistical approach to predict multiple possible outcomes – and predict microplastics concentrations in the human gut and body tissue. The updated model will provide direction to planned and ongoing research, offering qualitative and quantitative risk context. The project aims to: model microplastics with various size ranges (1 nm to 5 mm, with a primary focus on sizes from 100 nm to 5 mm; 25,400,000 nm = 1 inch); cover a wide range of foods and inhalation sources, including dust; and develop a user-friendly model that allows non-experts to perform analyses. The updated model is intended to simulate concentrations of microplastics in human organs and circulation, for example, modeling particle concentrations in lungs, lymphatic system, blood, and liver. The project aims to provide a list of recommendation for experimental work to refine processes and model parameters.

    Further details are available here.

    Professional Presentations

    Nor NHM, Koelmans AA. A conceptual model framework for the biodistribution of microplastics in the human body by using the Physiologically Based Pharamacokinetic (PBPK) model approach. EUROTOX: September 2023.

    Published Papers

    Wardani I, Nor NHM, Wright SL, Kooter IM, Kolemans AA (2024). Nano- and microplastic PBK modelling in the context of human exposure and risk assessment. Environment International: 108504; https://doi.org/10.1016/j.envint.2024.108504

  • Assessing microplastic inhalation toxicity

    April 16, 2024

    Researchers / Institutional Affiliations

    Principal Investigator

    • Dr. Tanja Hansen
      Fraunhofer Institute of Toxicology and Experimental Medicine
      (Germany)

    Collaborators

    • Dr. Wendel Wohlleben
      BASF
      (Germany)
    • Prof. Dr.-Ing. Silke Christiansen
      Fraunhofer Institute for Ceramic Technologies and Systems
      (Germany)

    Timeline

    January 2022 to April 2024.

    Additional Information

    Routes of human exposure to microplastics may including drinking water, food, and air pollution. Nano- and micro-plastic particles are detectable in numerous aquatic organisms and in human biomonitoring samples. This project used a tiered approach to assess the inhalation toxicity of various microplastics. Objectives included: identifying factors that determine inhalation toxicity; identifying existing approaches for other solid, inhalable particles that might be usefully applied to microplastics; using a tiered testing approach; ranking microplastics by their relevance for human risk assessment, specifically human hazard by inhalation; and based on the ranking, providing recommendations for confirmatory in vivo studies.

    Further details are available here.

    Professional Presentations

    Hansen T, Santizo K, Sarau G, Kolle S, Kraus A, Ritter D, Knebel J, Schwarz K, Escher S, Christiansen S, Wohlleben W. Towards a tiered strategy to assess microplastic inhalation toxicity. EUROTOX: September 2023.

    Santizo K, Mangold H, Wohlleben W, Sarau G, Christiansen S, Hansen T. Microplastic References for Inhalation Toxicity. Inhaled Particles Conference: May 2023.

    Published Papers

    N/A

  • Microplastic risk assessment and model development: Framework development and risk assessment model, upgrade and maintenance

    April 16, 2024

    Researchers / Institutional Affiliations

    • Framework development
      Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM; Germany)
    • Risk assessment model
      TBD
    • Risk assessment upgrade and maintenance
      TBD

    Timeline

    • Framework development: Q4 2023 to Q4 2024
    • Risk assessment model: Q2 2024 to Q4 2026
    • Risk assessment upgrade and maintenance: Q3 2025 to Q4 2026

    Additional information

    Working Package 4 (risk assessment and model development) will use data from Working Packages 2 (exposure assessment) and 3 (hazard assessment). This research is applying an innovative approach to risk assessment that combines traditional in vivo-based approach with elements from next-generation alternative techniques.

    Professional Presentations

    N/A

    Published Papers

    N/A

  • Microplastic risk assessment and model development: Hazard assessment: General, systemic, ex vivo and in vivo toxicities

    April 16, 2024

    Researchers / Institutional Affiliations

    • Cells: General toxicity
      Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek (TNO; The Netherlands)
    • Cells: Systemic toxicity
      TBD
    • Tissues: Ex vivo toxicity
      Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek (TNO; The Netherlands) The TIM Company (The Netherlands)
    • Organisms: In vivo toxicity
      TBD

    Timeline

    • Cells: General toxicity: Q1 to Q3 2025
    • Cells: Systemic toxicity: Q3 2025 to Q4 2026
    • Tissues: Ex vivo toxicity: Q4 2025 to Q1 2026
    • Organisms: In vivo toxicity: Q1 to Q2 2025

    Additional information

    Working Package 3 includes an investigation of the level of i) general toxicity in cell culture; ii) systemic toxicity in cell culture; iii) toxicity in tissues (including a gastrointestinal simulator and a liver model); and toxicity at the organism level.

    Professional Presentations

    N/A

    Published Papers

    N/A

  • Characterization of indoor and outdoor exposures to airborne microplastic particles

    April 16, 2024

    Collaborators

    • Alison Elder
      Environmental Medicine
      University of Rochester
      (Rochester, New York, US)
    • James McGrath
      Biomedical Engineering
      University of Rochester/SiMPore
    • Samantha Romanick
      Biomedical Engineering
      University of Rochester
      (Rochester, New York, US)
    • Wayne Knox
      Institute of Optics
      University of Rochester
      (Rochester, New York, US)
    • Andrew Berger
      Institute of Optics
      University of Rochester
      (Rochester, New York, US)
    • Gregory Madejski
      Integrated Nanosystems Center
      University of Rochester/Parverio, Inc.
      (Rochester, New York, US)
    • Iseult Lynch
      University of Birmingham (UK)
    • Sophie Comer-Warner
      University of Birmingham (UK)/University of Illinois Urbana-Champaign (Illinois, US)
    • John Scott
      University of Illinois Urbana-Champaign (Illinois, US)

    Timeline

    Analyses via Pyro-GC-MS to commence in spring 2024, with results being prepared for publication by the end of 2024

    Additional information

    Studies of indoor and outdoor air and settled dust have found plastic particles with varying compositions (polypropylene, polyethylene, polyester, polyvinyl chloride, nylon), morphologies (fibers, fragments, spheres), and sizes, including submicrometer particles up to several mm long. At least for larger size fractions, plastic particles can be distinguished from other airborne particulates. This project aims to address data gaps including defining the concentration, morphology, and composition of particles that can be deposited in the respiratory tract.

    For the airborne microplastic studies, researchers are using respirable cyclone-type (4 μm) and fine particulate matter (PM2.5 impactor-type, ≤2.5 μm) sampling devices. Several samples have been collected on ultrathin, optically clear silicon nanomembranes that allow imaging without extraction. For initial experiments, particles were stained to identify cellulosic and polymeric particles. The samples collected on the membranes are being analyzed via light microscopy or confocal Raman spectroscopy. However, the methods described above have limitations in terms of minimum particle sizes and the speciation analyses are somewhat inefficient. On this latter point, most health-based standards relating to particulate matter are expressed by mass concentration. Thus, the researchers are currently preparing for bulk analyses of respirable samples via pyrolysis gas chromatography/mass spectrometry (GC-MS).

    Results will ultimately be extrapolated to estimate lung burdens over various exposure time scales to compare to other types of environmental and occupational exposures. These quantitative analyses are complemented by imaging analyses to provide information about morphology and physical dimensions, as well as exploratory work to identify microplastics in environmental samples.

    Professional Presentations

    Elder et al. Analysis of Airborne Microplastics in Indoor Environments: Toxicological Considerations (virtual talk). Society for Risk Analysis annual conference, December 2021.

    Romanick et al. National Postdoc Appreciation Week Showcase, 2021 (University of Rochester): Assessment of Respirable and Inhalable Indoor Microplastic Pollution (poster).

    Elder et al. Are Airborne Microplastics a New Concern for Human Health? (talk). Society of Toxicology-Japanese Society of Toxicology Joint Symposium, SOT annual conference, San Diego, CA, March 2022.

    Romanick et al. Assessment of Respirable and Inhalable Household Microplastic Pollution and the Effects of Exposure on the Human Epithelial Barrier. 2022 Society of Toxicology poster presentation (San Diego, CA).

    Elder et al. Evaluating Indoor Exposures to Human Respirable Microplastic Particles (talk). Inhaled Particles Toxicology Conference, Santa Fe, NM, August 2022.

    Elder et al. Evaluating Indoor Exposures to Human Respirable Microplastic Particles (virtual talk). Microplastics Advance Research and Innovation Initiative (MARII) Workshop on advancements and steps towards a holistic, quantitative risk assessment on microplastics, October 2022.

    Elder et al. Evaluating Airborne Exposures to Microplastic Particles (talk). Microplastics: Factors to Consider when Assessing Potential Environmental and Human Health Risks Symposium, SOT annual conference, Nashville, TN, March 2023.

    Romanick et al. Colorimetric Assessment of Household Settled Dust Captured on Silicon Nanomembranes. 2023 Society of Toxicology poster presentation (Nashville, TN).

    Romanick et al. Colorimetric Assessment of Household Settled Dust Captured on Silicon Nanomembranes (talk). Inhaled Particles XIII-NanOEH Conference, May 2023 (Manchester, UK).

    Elder et al. Evaluating Airborne Exposures to Microplastic Particles (talk). Inhaled Particles XIII-NanOEH Conference, May 2023 (Manchester, UK).

    Published Papers

    Publications in Preparation:

    Romanick SS, Madejski G, Cashion G, Berger AJ, Elder A, McGrath J. Assessment of Household
    Settled Dust via Silicon Nanomembrane Analyses Pipeline (SNAP); Submitted.

    The researchers are also preparing an overview paper and a protocol paper about the characterization of microplastics in household dust.

    Alison Elder and Phoebe Stapleton (Rutgers University) are collaboration to prepare a chapter for Comprehensive Toxicology, 4th edition entitled, Nanoparticles and nanoplastics in the Lung; due for submission by June 2024

  • Microplastics systematic review for mammalian developmental and reproductive toxicity endpoints

    April 13, 2024

    Researchers / Institutional Affiliations

    • Seneca Fitch, Daniele Wikoff & John Rogers
      ToxStrategies, LLC
      (US)
    • Steffen Schneider & Bjoern Hidding
      BASF
      (Germany)
    • Sue Marty & Robert Ellis-Hutchings
      Dow, Inc
      (US)
    • Erik Rushton
      LyondellBasell
      (The Netherlands)

    Timeline

    Completion 3Q24

    Additional Information

    Professional Presentations

    Fitch S, Rogers J, Marty S, Ellis-Hutchings R, Becker R, Wikoff D. Development of a Study Quality Tool for Use in a Systematic Review of Literature Reporting Microplastic Exposure and
    Reproductive and Developmental Toxicity
    . Society of Toxicology’s 62nd Annual Meeting, March 2023, Nashville Tennessee (US).

    Fitch S, Ellis-Hutchings R, Rogers J, Marty S, Rushton E, Schneider S, Otte J, Norman J, Wikoff D. Study quality evaluation of literature reporting plastic microparticle exposure against
    reproductive and developmental toxicity endpoint. Society of Toxicology’s 63rd Annual Meeting, March 2024, Salt Lake City, Utah (US).

    Published Papers

    (IN DRAFT) Seneca Fitch, John Rogers, Allison Franzen, Robert Ellis-Hutchings, Sue Marty, Jens Otte, Erik Rushton, Susan Borghoff, Daniele Wikoff. DRAFT. Systematic Review of Microplastics and Potential Developmental and Reproductive Toxicity. Unsubmitted.

  • Microplastic risk assessment and model development: Exposure assessment: In silico model, transfer across barriers, in vivo tracking, human stool study

    April 13, 2024

    Researchers / Institutional Affiliations

    • In silico exposure model:
      Wageningen University and Research (WUR; The Netherlands)
    • Transfer across barriers:
      Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek (TNO; The
      Netherlands)
      BASF (Germany)
    • In vivo tracking study:
      Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek (TNO; The
      Netherlands)
      Charles River Laboratories
    • Human stool study:
      Environment Agency Austria (UBA; Austria)

    Timeline

    • In silico exposure model: Q1 2022 to Q1 2026
    • Transfer across barriers: Q3 2024 to Q1 2025
    • In vivo tracking study: Q3 2024 to Q1 2025
    • Human stool study: Q3 2023 to Q1 2024

    Funding Source

    Plastics Europe, Task 2.i. co-funded by Cefic-LRI (as project B24)

    Additional information

    The objective of Working Package 2 is to confirm and track the presence of microplastics in the
    human body. There is a focus on: an in silico human exposure computer model, being built in
    collaboration with Cefic-LRI project B24; transfer across barriers, using cell-culture assays to
    establish the potential for microplastics to cross biological membranes; an in vivo tracking study
    using model organisms; and a human stool study aimed at counting and characterizing
    microplastics in human stool.

    Professional Presentations

    N/A

    Published Papers

    Nano- and microplastic PBK modeling in the context of human exposure and risk
    assessment. Wardani et al. 2024. Environment International 186: 108504.
    https://doi.org/10.1016/j.envint.2024.108504.

MARII
  • LinkedIn
  • X

© Copyright 2025 International Council of Chemical Associations. All Rights Reserved. Privacy Policy